2011
5-Year Follow-Up of Polytetrafluoroethylene-Covered Stents Compared With Bare-Metal Stents in Aortocoronary Saphenous Vein Grafts The Randomized BARRICADE (Barrier Approach to Restenosis: Restrict Intima to Curtail Adverse Events) Trial
Stone GW, Goldberg S, O'Shaughnessy C, Midei M, Siegel RM, Cristea E, Dangas G, Lansky AJ, Mehran R. 5-Year Follow-Up of Polytetrafluoroethylene-Covered Stents Compared With Bare-Metal Stents in Aortocoronary Saphenous Vein Grafts The Randomized BARRICADE (Barrier Approach to Restenosis: Restrict Intima to Curtail Adverse Events) Trial. JACC Cardiovascular Interventions 2011, 4: 300-309. PMID: 21435608, DOI: 10.1016/j.jcin.2010.11.013.Peer-Reviewed Original ResearchMeSH KeywordsAgedAngioplasty, Balloon, CoronaryChi-Square DistributionCoated Materials, BiocompatibleCoronary AngiographyCoronary Artery BypassCoronary RestenosisFemaleGraft Occlusion, VascularHumansKaplan-Meier EstimateMaleMetalsMiddle AgedMyocardial InfarctionPlatelet Aggregation InhibitorsPolytetrafluoroethyleneProspective StudiesProsthesis DesignRisk AssessmentRisk FactorsSaphenous VeinStentsThrombosisTime FactorsTreatment OutcomeUnited StatesConceptsSaphenous vein graftsBare metal stentsPercutaneous coronary interventionDiseased saphenous vein graftsHigh-pressure implantationDual antiplatelet therapyTarget vessel failureAntiplatelet therapyMajor secondary end pointEnd pointPrimary end pointSecondary end pointsLong-term prognosisBinary restenosisBMS patientsCoronary interventionVein graftsVessel failureInferior outcomesSaphenous veinDiscrete lesionsPatientsPrior trialsJostentLesions
2010
Clinical Follow-Up 3 Years After Everolimus- and Paclitaxel-Eluting Stents A Pooled Analysis From the SPIRIT II (A Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions) and SPIRIT III (A Clinical Evaluation of the Investigational Device XIENCE V Everolimus Eluting Coronary Stent System [EECSS] in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) Randomized Trials
Caixeta A, Lansky AJ, Serruys PW, Hermiller JB, Ruygrok P, Onuma Y, Gordon P, Yaqub M, Miquel-Hebert K, Veldhof S, Sood P, Su X, Jonnavithula L, Sudhir K, Stone GW, Investigators S. Clinical Follow-Up 3 Years After Everolimus- and Paclitaxel-Eluting Stents A Pooled Analysis From the SPIRIT II (A Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions) and SPIRIT III (A Clinical Evaluation of the Investigational Device XIENCE V Everolimus Eluting Coronary Stent System [EECSS] in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) Randomized Trials. JACC Cardiovascular Interventions 2010, 3: 1220-1228. PMID: 21232715, DOI: 10.1016/j.jcin.2010.07.017.Peer-Reviewed Original ResearchMeSH KeywordsAngioplasty, Balloon, CoronaryAntineoplastic Agents, PhytogenicAspirinClopidogrelConfidence IntervalsCoronary Artery DiseaseDrug-Eluting StentsEverolimusFemaleFollow-Up StudiesHumansImmunosuppressive AgentsKaplan-Meier EstimateLogistic ModelsMaleMiddle AgedPaclitaxelPlatelet Aggregation InhibitorsProportional Hazards ModelsRandomized Controlled Trials as TopicRiskRisk Reduction BehaviorSirolimusTiclopidineTime FactorsConceptsMajor adverse cardiac eventsPaclitaxel-eluting stentsAdverse cardiac eventsTarget vessel failureCardiac eventsMyocardial infarctionSPIRIT IIProbable stent thrombosisAcademic Research ConsortiumEverolimus-eluting stentsVessel failureSignificant reductionLesion revascularizationPES patientsRevascularization eventsIII trialsClinical outcomesEE patientsStent thrombosisPooled analysisCumulative ratePersistent reductionSPIRIT IIIPatientsStents
2005
Intravascular ultrasound assessment of lesions with target vessel failure after sirolimus-eluting stent implantation
Takebayashi H, Kobayashi Y, Mintz GS, Carlier SG, Fujii K, Yasuda T, Moussa I, Mehran R, Dangas GD, Collins MB, Kreps E, Lansky AJ, Stone GW, Leon MB, Moses JW. Intravascular ultrasound assessment of lesions with target vessel failure after sirolimus-eluting stent implantation. The American Journal Of Cardiology 2005, 95: 498-502. PMID: 15695138, DOI: 10.1016/j.amjcard.2004.10.020.Peer-Reviewed Original ResearchConceptsSirolimus-eluting stent implantationTarget vessel failureIntravascular ultrasound evaluationMinimum stent areaIntravascular ultrasound assessmentStent restenosesNew stenosisNew lesionsUltrasound evaluationNegative remodelingStent implantationUltrasound assessmentPlaque areaStent areaStent failureLesionsRestenosesVessel failureFailureThrombosesStenosisPatients
2001
Final results of a randomized trial comparing the MULTI-LINK stent with the Palmaz-Schatz stent for narrowings in native coronary arteries
Baim D, Cutlip D, Midei M, Linnemeier T, Schreiber T, Cox D, Kereiakes D, Popma J, Robertson L, Prince R, Lansky A, Ho K, Kuntz R, Investigators A. Final results of a randomized trial comparing the MULTI-LINK stent with the Palmaz-Schatz stent for narrowings in native coronary arteries. The American Journal Of Cardiology 2001, 87: 157-162. PMID: 11152831, DOI: 10.1016/s0002-9149(00)01308-4.Peer-Reviewed Original ResearchConceptsTarget vessel failurePS stentPalmaz-SchatzMajor adverse cardiac eventsNative vessel lesionsAdverse cardiac eventsPrimary end pointNative coronary arteriesSuccessful stent deliveryPalmaz-Schatz stentsAngiographic outcomesCardiac eventsAngiographic restudyAcute resultsDiameter stenosisVessel lesionsCoronary arteryVessel failureClinical equivalenceStent deliveryNonsignificant trendPatientsExcellent deliverabilityEnd pointStentsFinal results of a randomized trial comparing the NIR stent to the Palmaz-Schatz stent for narrowings in native coronary arteries
Baim D, Cutlip D, O’Shaughnessy C, Hermiller J, Kereiakes D, Giambartolomei A, Katz S, Lansky A, Fitzpatrick M, Popma J, Ho K, Leon M, Kuntz R, Investigators N. Final results of a randomized trial comparing the NIR stent to the Palmaz-Schatz stent for narrowings in native coronary arteries. The American Journal Of Cardiology 2001, 87: 152-156. PMID: 11152830, DOI: 10.1016/s0002-9149(00)01307-2.Peer-Reviewed Original ResearchConceptsPrimary end pointTarget vessel failureNIR stentPS stentBetter acute angiographic resultsTarget vessel failure rateMajor adverse cardiac eventsEnd pointSingle coronary lesionsAdverse cardiac eventsNative coronary arteriesNorth American trialsSuccessful stent deliveryAcute angiographic resultsPalmaz-Schatz stentsPrespecified cohortCardiac eventsAngiographic restudyAngiographic resultsCoronary lesionsPS patientsDiameter stenosisCoronary arteryVessel failureStent placement